Consumer, Finance & markets, Health · 24 h
48 storiesChina medical insurance pooled funds take in 2.07 trillion yuan in Jan-Aug
China's National Healthcare Security Administration released data showing that in January to August 2026 the basic medical insurance (including maternity insurance) pooled funds took in 2.072772 trillion yuan and spent 1.550414 trillion yua…
Celltrion's Avtozma wins FDA nod for pediatric COVID-19 use in US
Celltrion said the US Food and Drug Administration granted an additional approval for its Avtozma (tocilizumab) intravenous formulation to treat COVID-19 in patients aged 2 and older. The approval widens the drug's COVID-19 indication from …
KOSPI opens down 1.11% at 6,864.25; KOSDAQ falls 0.27%
South Korea’s KOSPI opened 77.14 points, or 1.11%, lower at 6,864.25 on 7 October, while the KOSDAQ opened down 2.47 points, or 0.27%, at 917.45. The benchmark index rebounded to 6,944.83 by 09:25 as individual investors bought, then fell b…
South Korea study links severe gestational diabetes to higher diabetes risk in children
South Korea's National Institute of Health said children of mothers who had gestational diabetes are more likely to develop diabetes, with the risk rising to 4.3 times for type 2 diabetes among children of mothers who needed insulin during …
Bank of Korea appoints Choi Young-ju deputy governor, taps Yoon Kyung-su for research
The Bank of Korea appointed Choi Young-ju, head of its Financial Markets Bureau, as deputy governor in charge of international and financial cooperation, filling a post that had been vacant, the bank said on October 7. Her term runs from Oc…
WHO and Russia say no further plague infections after Siberian lab worker's death
A female worker at the Irkutsk Anti-Plague Institute of Siberia and the Far East died last week from pneumonia of undetermined origin, according to Russian authorities and the WHO. Russia's Rospotrebnadzor said 60% of the identified contact…
China's central bank raises gold reserves for 23rd straight month
China's gold reserves stood at 77.47 million ounces, or about 2,409.59 tonnes, at the end of September, up 740,000 ounces (about 23.02 tonnes) from 76.73 million ounces (about 2,386.57 tonnes) a month earlier, according to figures carried b…
Kenya confirms first Ebola death after patient arrives from Congo via Uganda
Kenya’s Health Ministry confirmed the country’s first imported Ebola case on Tuesday, after a Kenyan man who arrived from the Democratic Republic of Congo via Uganda was treated at Nairobi Hospital and died late Monday. Authorities placed K…
Samsung Securities to launch second issuance-note tranche on Oct 12 at 4.3%
Samsung Securities said it will begin selling a second special tranche of issuance notes from Oct 12, a one-year product at 4.3% a year before tax with a 100 billion won limit. The first tranche, launched Sept 21, sold out in two and a half…
Goldman Sachs warns Samsung volatility may spike on Oct. 8 events
Goldman Sachs said Samsung Electronics shares could swing sharply on October 8, when preliminary third-quarter results fall on the same day as semiconductor ETF rebalancing, options expiry and the end of a share buyback. The bank cut its th…
GC Cell starts Phase 1b trial of GCC2005 in T-cell lymphoma, first patient dosed
GC Cell said on Oct 7 that its drug candidate GCC2005 (CD5 CAR-NK), a cell therapy for T-cell lymphoma, has entered a Phase 1b trial and that the first subject has been dosed. The company completed the dose-escalation stage of Phase 1a and …
Hong Kong-listed semiconductor shares fall, Lanqi Technology down nearly 8%
Hong Kong-listed semiconductor stocks fell collectively on October 7, with Lanqi Technology down nearly 8%, according to CLS and Jiemian. Aixin Yuanzhi fell more than 5%, while Naxin Micro, Jinghe Integrated and Zhaoyi Innovation each dropp…
Korea Investment Securities, AQR discuss bringing global quant funds to Korea
Korea Investment Securities said its president, Kim Sung-hwan, met AQR Capital Management co-founder John M. Liew at its Seoul headquarters on October 6 to discuss supplying AQR's global quant and alternative investment products to Korean i…
IMF warns rapid hedge fund growth could amplify market risk
The IMF said in the second chapter of its Global Financial Stability Report, released on 6 October, that hedge fund risks to macro-financial stability need close attention, because fast asset growth can amplify price dislocations and liquid…
Hong Kong pharma shares weaken; 金斯瑞生物科技 falls 13.72%
Hong Kong-listed pharmaceutical shares mostly weakened on Oct 7, 2026. 金斯瑞生物科技 (01548.HK) fell 13.72% and 昭衍新药 (06127.HK) fell 11.93% as of 09:49 local time, with Jiemian reporting the same figures at 10:22. Yicai reported the sector was mo…
New York comptroller projects Wall Street profits above $90bn, record bonuses
New York State Comptroller Thomas DiNapoli estimated the state's securities industry will earn more than $90 billion (about 120 trillion won) this year, up from $65.1 billion last year, and that Wall Street bonuses will rise again to a reco…
Woman, 55, who collapsed on Vietnam trip donates organs to three
A 55-year-old South Korean woman, Ku Jin-hui, collapsed with a brain hemorrhage while traveling in Vietnam with her daughter on Sept. 12 and was later declared brain dead. The Korea Organ and Tissue Donation Agency said she donated her live…
Secondhand platform Bungaejangter to hold first “Bungae Day” on Oct 9
Bungaejangter, a South Korean secondhand goods platform, said it will hold its first one-day “Bungae Day” shopping event on Oct 9, Hangul Day, with instant discount coupons for purchases made through its safe payment. The company said the c…
Seoul pharma and diagnostics stocks jump on report of Russian plague lab researcher’s death
A researcher at a plague research institute in Irkutsk, Russia, died on Oct 2 after being hospitalised with severe pneumonia on Sept 29, and Russian media reports of a broken pathogen vial raised the possibility of plague infection, though …
HLB says EMA begins main review of bile duct cancer drug lirafugratinib
HLB’s US subsidiary Eleba Therapeutics said the European Medicines Agency has begun the main review of its marketing authorisation application for the bile duct cancer drug lirafugratinib. Asia Economy reported the European filing was made …